New diagnostic tests: more harm than good | The BM...
graber.mark at GMAIL.COM
Thu Jul 20 16:46:23 UTC 2017
Thanks to Stephen Martin for forwarding this new article from Bjorn Hofmann and Gilbert Welch that looks at the benefits vs harms (and cost) of 4 new tests: immunosignature testing, breath tests for lung cancer, patch vital sign monitoring, and biomarkers for Alzheimer’s disease. The title of the article summarizes their conclusions.
Mark L Graber, MD FACP
Senior Fellow, RTI International
Professor Emeritus, Stony Brook University, NY
Moderator: David Meyers, Board Member, Society to Improve Diagnosis in Medicine
Size: 22016 bytes
Desc: not available
More information about the Test